ArticleACS pharmacology & translational science2025

Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease.

Zonghui Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.